Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Other Non Operating Income (2018 - 2019)

Sonoma Pharmaceuticals has reported Other Non Operating Income over the past 9 years, most recently at -$134000.0 for Q4 2019.

  • For Q4 2019, Other Non Operating Income fell 709.09% year-over-year to -$134000.0; the TTM value through Dec 2019 reached -$112000.0, down 609.09%, while the annual FY2022 figure was $723000.0, N/A changed from the prior year.
  • Other Non Operating Income for Q4 2019 was -$134000.0 at Sonoma Pharmaceuticals, down from $22000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $3.2 million in Q1 2015 and troughed at -$134000.0 in Q4 2019.
  • A 4-year average of $456000.0 and a median of $22000.0 in 2018 define the central range for Other Non Operating Income.
  • Biggest five-year swings in Other Non Operating Income: decreased 20.0% in 2015 and later tumbled 709.09% in 2019.
  • Year by year, Other Non Operating Income stood at $4000.0 in 2015, then plummeted by 75.0% to $1000.0 in 2016, then soared by 2100.0% to $22000.0 in 2018, then tumbled by 709.09% to -$134000.0 in 2019.
  • Business Quant data shows Other Non Operating Income for SNOA at -$134000.0 in Q4 2019, $22000.0 in Q4 2018, and $1000.0 in Q1 2016.